87771-40-2
Chemical Structure
Ioversol
Synonym(s): MP-328
- CAS No.: 87771-40-2
- Formula:C18H24I3N3O9
- Molecular Weight:807.11
IUPAC Name: N1,N3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-(2-hydroxyethyl)acetamido)-2,4,6-triiodoisophthalamide
InChIKey: AMDBBAQNWSUWGN-UHFFFAOYSA-N
SMILES: O=C(C1=C(I)C(N(C(CO)=O)CCO)=C(I)C(C(NCC(O)CO)=O)=C1I)NCC(O)CO
Biological Activity: Ioversol (MP-328) is a nonionic iodinated contrast medium (CM) that is used during a CT scan or x-ray in animal experiment. Ioversol does not damage the blood-brain barrier (BBB) in animal[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ioversol | 98.0% | Ioversol (MP-328) is a nonionic iodinated contrast medium (CM) that is used during a CT scan or x-ray in animal experiment. Ioversol does not damage the blood-brain barrier (BBB) in animal. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ioversol (Standard) | ≥98% | Ioversol (Standard) is the analytical standard of Ioversol. This product is intended for research and analytical applications. Ioversol (MP-328) is a nonionic iodinated contrast medium (CM) that is used during a CT scan or x-ray in animal experiment. Ioversol does not damage the blood-brain barrier (BBB) in animal. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Yang D, et al. Selective inhibition of the reverse mode of Na(+)/Ca(2+) exchanger attenuates contrast-induced cell injury. Am J Nephrol. 2013;37(3):264-73. doi: 10.1159/000348526. Epub 2013 Mar 13. [Content Brief]
- [2]. Heyman SN, et al. Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol. 1993 Apr;28(4):313-8. [Content Brief]
- [3]. J Ueda, et al. Elimination of ioversol by hemodialysis. Acta Radiol. 1996 Sep;37(5):826-9. [Content Brief]
- [4]. N Motoji , et al. Comparison of the effects of ioversol and other contrast media on the blood-brain barrier. Biol Pharm Bull. 1994 Feb;17(2):257-61. [Content Brief]
Keywords